An interventional study of electronic colonoscopy in Anastomotic Leakage, sponsored by Nanchong Central Hospital. Recruiting at 1 site in China. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-11-16.
Sponsored by Nanchong Central Hospital · Not applicable, Interventional, and Diagnostic
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 46 studies in Anastomotic Leak with a site in China — 20 open to participants now, 22 under way, 1 of them phase 3. Anastomotic Leak · China.
Among the 46 studies in Anastomotic Leak with a site in China, this one is the 22nd largest by planned enrollment of the 30 interventional ones that give a count, is one of 4 that started in 2026, is one of 24 with no phase, reaches primary completion later than 14 of the 21 other live ones, and was the 43rd registered.
240 studies on the registry are indexed under Anastomotic Leak; 72 are open to participants now.
Browse Anastomotic Leak studies →20 of the 46 studies in Anastomotic Leak with a site in China are open now. Recruiting first, the newest first:
Nanfang Hospital, Southern Medical University · Sites in China
Ages 18–75
Tongji Hospital · Sites in China
Ages 18–75
Nanchong Central Hospital · Sites in China
Ages 18–85
Third Military Medical University · Sites in China
Ages 18–80
Nanchong Central Hospital · Sites in China
Ages 18–85
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 45 Anastomotic Leak studies recruiting now, 23 (51%) set no upper age limit and 11 (24%) stop at 75 or younger; 1 takes children under 18; 1 takes healthy volunteers.
This study: 18 Years to 80 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
46 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 5 · Phase 3 2
First in 2011; this study’s year is marked. 4 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 140 is close to the median of 140 across 128 interventional studies indexed under Anastomotic Leak.
Median enrollment 253 across the 30 interventional studies, 350 across the 16 observational. Of the 14 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 46 has an industry lead sponsor. The 10 most frequent:
Nanchong Central Hospital is the lead sponsor of 21 studies on the registry; 14 are open to participants now.
Nanchong Central Hospital has 5 studies filed under Anastomotic Leak — fewer than ten, so there is no comparison to draw.
5 of the studies in Anastomotic Leak with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07376876Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityIndocyanine Green-guided Omental Shield Anastomosis for Cervical Esophagogastric Anastomosis in Minimally Invasive McKeown Esophagectomy | 2026-12-31 |
| NCT07726966Southwest Hospital, ChinaBetacyanin for Early Diagnosis and Recovery of Anastomotic Leakage After Rectal Cancer Surgery: A Single-Center, Prospective, Controlled Trial | 2027-05-01 |
| NCT07588386Nanchong Central HospitalThe Value of Early Postoperative Colonoscopy in The Early Diagnosis of Anastomotic Leakage After Surgery for Low Colorectal Cancer | 2027-06-30 |
| NCT07605611Tongji HospitalSomatostatin Plus Clear Liquid Diet Versus Diverting Stoma in Patients With Rectal Cancer Undergoing Ultra-Low Anterior Resection | 2027-07-31 |
| NCT05943444Sixth Affiliated Hospital, Sun Yat-sen UniversityComparison of Postoperative Anal Function Between Parks and Bacon Techniques in Low Rectal Cancer | 2027-08-08 |
Add all 5 to your calendar (.ics) → With an account.
Among the 46 studies in Anastomotic Leak with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to learn whether early postoperative colonoscopy is valuable in the early diagnosis of anastomotic leakage after surgery for low colorectal cancer.The main questions it aims to answer are:
Researchers will compare the median diagnosis time of AL in the intervention group (early colonoscopy group) with the control group to observe whether early postoperative colonoscopy can detect anastomotic leakage earlier.
Participants will:
Experimental group (early colonoscopy group):
Control group (routine observation group):
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The diagnosis was confirmed by looking at a sample under a microscope: tissue from a biopsy or surgery (histology), or cells from a fluid or needle sample (cytology).
Your pathology report is the document that shows this.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Histologically or cytologically confirmed
The diagnosis was confirmed by looking at a sample under a microscope: tissue from a biopsy or surgery (histology), or cells from a fluid or needle sample (cytology).
Your pathology report is the document that shows this.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Metastases
Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Behavioral: electronic colonoscopy
Colonoscopy on days 5 to 8 after colorectal cancer surgery
Diagnosis time lag: the number of days from the end of the operation (the last stitch of skin suturing) to the final diagnosis of AL (confirmed by imaging, endoscopic or surgical exploration).
Time frame: day 30
Diagnostic efficacy: The sensitivity and specificity of early colonoscopy in diagnosing AL, etc.
Time frame: day 8
Clinical outcomes: AL incidence rate within 30 days (divided into grades A, B, and C).
Time frame: day 30
Total postoperative days of hospitalization.
Time frame: 2 months
Safety indicators: the incidence of complications (such as bleeding, perforation, cardiovascular events) directly related to early enteroscopy.
Time frame: 1 month
Started Jun 2026 (actual). Primary completion is estimated for Jun 2027, 12 months after the start.
Of 59 non-industry interventional studies with no phase under Anastomotic Leak, half reached primary completion within 32 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 42. This study's planned 12 months is below that.
Counting every sponsor, half of 66 studies reached it within 32 months; a quarter within 19 and three quarters within 42.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Nanchong Central Hospital